T1	HMM 703 762	Echocardiographic, hemodynamic, and biochemical assessments
T2	HMM 914 1033	End-systolic wall stress, the left ventricular ejection fraction, pulmonary capillary wedge pressure, and cardiac index
T3	HMM 1145 1253	Plasma N-terminal-pro-B-type natriuretic peptide, tumor necrosis factor-alpha, and soluble Fas ligand levels
T4	HMM 1466 1479	interleukin-6
T5	HMM 1521 1579	Levosimendan-induced reduction in end-systolic wall stress
T6	HMM 1638 1679	N-terminal-pro-B-type natriuretic peptide
T7	HMM 1702 1729	tumor necrosis factor-alpha
T8	HMM 1752 1763	soluble Fas
T9	HMM 1790 1808	soluble Fas ligand
T10	HMM 1831 1850	Event-free survival
T11	HMM 1989 2009	central hemodynamics
T12	HMM 2014 2042	left ventricular performance
